Related Experiment Video

Updated: May 23, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Combining immunotherapy and targeted therapies in cancer treatment

Matthew Vanneman1, Glenn Dranoff

  • 1Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.

Nature Reviews. Cancer
|March 23, 2012
PubMed

Insights

Cancer treatment has shifted from cytotoxic agents to targeted therapies and immunotherapy. Combining these approaches may improve patient outcomes by enhancing immune responses against tumors.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Cancer treatment has evolved from non-specific cytotoxic agents to targeted therapies and immunotherapy.
  • Traditional chemotherapy has limitations including toxicity and resistance.
  • Newer approaches leverage a deeper understanding of cancer biology.

Purpose of the Study:

  • To review the evolution of cancer treatment paradigms.
  • To discuss targeted agents and cancer immunotherapy.
  • To explore the potential of combining treatment strategies.

Main Methods:

  • Literature review of cancer treatment evolution.
  • Analysis of targeted therapy mechanisms.
  • Examination of immunotherapy principles.
  • Discussion of drug interactions and immune modulation.

Main Results:

  • Cancer treatment has progressed to mechanism-based therapeutics.
  • Targeted therapies inhibit crucial tumor pathways.
  • Immunotherapy stimulates anti-tumor immune responses.
  • Cytotoxic agents and targeted therapies influence immune systems.

Conclusions:

  • Combination therapies integrating targeted agents, cytotoxic drugs, and immunotherapy hold promise.
  • Modulation of immune responses by current treatments suggests synergistic potential.
  • Further research into combination strategies may improve clinical outcomes in cancer care.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...